Abstract
The goal of molecular imaging is to detect pathologic biomarkers, which can lead to early recognition of diseases, better therapeutic management, and improved monitoring for recurrence. MRI is a particularly attractive method for molecular imaging applications, due to its noninvasive nature, outstanding signal to noise ratio, high spatial resolution, exceptional tissue contrast, and short imaging times. Site-specific MRI contrast agents have been developed to target biologic processes that occur early in the development of atherosclerotic plaques, including angiogenesis and lipid accumulation, or biosignatures that appear later, such as fibrin and tissue factor resulting from plaque rupture. Moreover, targeted contrast agents can also serve as drug delivery vehicles, combining diagnosis and therapy. If ultimately successful, these emerging molecular imaging agents and techniques will allow early disease recognition and quantification prompting therapeutic intervention before serious sequelae ensue.
References
Dec 15, 1996·Circulation·G M LanzaS A Wickline
Oct 25, 2000·Circulation·S OjioH Fujiwara
Dec 7, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·X YuG M Lanza
Apr 11, 2001·Circulation·G G BishopI J Sarembock
Jul 19, 2001·Bioconjugate Chemistry·M MikawaH Shinohara
Sep 12, 2001·Circulation·S FlackeG M Lanza
Nov 27, 2002·Circulation·Gregory M LanzaSamuel A Wickline
Mar 5, 2003·Circulation·Samuel A Wickline, Gregory M Lanza
Jul 24, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Patrick M WinterGregory M Lanza
Oct 8, 2003·Circulation·Morteza NaghaviJames T Willerson
Oct 15, 2003·Circulation·Patrick M WinterSamuel A Wickline
Mar 9, 2004·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Anne M MorawskiSamuel A Wickline
Jul 21, 2004·Trends in Cardiovascular Medicine·William P Fay
Dec 17, 2004·Journal of the American Chemical Society·Juan C FriasZahi A Fayad
Feb 8, 2005·Radiologic Clinics of North America·Edward J Delikatny, Harish Poptani
Apr 29, 2005·The International Journal of Cardiovascular Imaging·L M MitsumoriC Yuan
Aug 18, 2005·Academic Radiology·Patrick M WinterGregory M Lanza
Aug 24, 2005·Atherosclerosis·Marc SirolZahi A Fayad
Citations
Sep 12, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Weibo CaiXiaoyuan Chen
Sep 23, 2008·Bioconjugate Chemistry·Paul J EndresThomas J Meade
Dec 30, 2009·Nano Letters·Lisa M ManusThomas J Meade
Jul 20, 2012·ACS Nano·Santimukul SantraJ Manuel Perez
Jul 10, 2009·Chemical Communications : Chem Comm·Dipanjan PanGregory M Lanza
Aug 10, 2010·Nanoscale·Fengqin HuThomas J Meade
Aug 25, 2007·Nanomedicine·Willem J M MulderZahi A Fayad
Apr 30, 2009·Radiology·Marlies OostendorpWalter H Backes
Jul 16, 2014·Scientifica·Patrick M Winter
Mar 10, 2009·Current Problems in Cardiology·Birgit KantorThomas C Gerber
Nov 21, 2015·Journal of Molecular Evolution·Cheng JinWeihong Tan
Oct 13, 2006·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Liz Warburton, Jonathan Gillard
May 25, 2011·Journal of Thrombosis and Haemostasis : JTH·J MyersonS Wickline
Jun 24, 2010·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Marlies OostendorpWalter H Backes
Jul 1, 2006·Drug Discovery Today. Technologies·Steven R MeikleStephen E Rose
Apr 4, 2008·Chemistry : a European Journal·Elisa BattistiniPhilippe Durand
Nov 3, 2009·Angewandte Chemie·Ying SongThomas J Meade
Mar 28, 2013·Journal of Medical Physics·Saeed ShanehsazzadehFariba Johari Daha
Apr 22, 2011·Nanotechnology·Fengqin HuMingyuan Gao
Mar 16, 2007·Expert Review of Medical Devices·Patrick M WinterGregory M Lanza
Sep 6, 2020·International Journal of Molecular Sciences·Gengqi LiuYumiao Zhang
Sep 20, 2006·Cancer Research·Simonetta Geninatti CrichSilvio Aime
Apr 4, 2021·Cancers·Katsuo UsudaHidetaka Uramoto